BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 11734663)

  • 1. Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis.
    Boyanovsky B; Russeva M; Ganev V; Penev M; Baleva M
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):639-42. PubMed ID: 11734663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
    Martinelli I; Battaglioli T; Razzari C; Mannucci PM
    J Thromb Haemost; 2007 Jan; 5(1):98-101. PubMed ID: 17067362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism.
    de Moerloose P; Reber G; Perrier A; Perneger T; Bounameaux H
    Br J Haematol; 2000 Jul; 110(1):125-9. PubMed ID: 10930988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
    Margaglione M; Brancaccio V; De Lucia D; Martinelli I; Ciampa A; Grandone E; Di Minno G
    Chest; 2000 Nov; 118(5):1405-11. PubMed ID: 11083693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.
    Jun ZJ; Ping T; Lei Y; Li L; Ming SY; Jing W
    Clin Lab Haematol; 2006 Apr; 28(2):111-6. PubMed ID: 16630215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism?
    Chevalier Y; Mandrillon G; Bestion A; Lega JC; Piquet P; Ninet J; Dargaud Y
    Int Angiol; 2014 Aug; 33(4):404-5. PubMed ID: 25056173
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
    Martinelli I; Bucciarelli P; Margaglione M; De Stefano V; Castaman G; Mannucci PM
    Br J Haematol; 2000 Dec; 111(4):1223-9. PubMed ID: 11167765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter.
    Mandalà M; Curigliano G; Bucciarelli P; Ferretti G; Mannucci PM; Colleoni M; Ventura A; Peruzzotti G; Severi G; Pelicci PG; Biffi R; Orsi F; Cinieri S; Goldhirsch A
    Ann Oncol; 2004 Apr; 15(4):590-3. PubMed ID: 15033664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence.
    Simsek E; Yesilyurt A; Pinarli F; Eyerci N; Ulus AT
    Gene; 2014 Feb; 536(1):171-6. PubMed ID: 24334115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of Factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes].
    Alvarez A; Barroso A; Robledo M; Arranz E; Outeiriño J; Benítez J
    Sangre (Barc); 1999 Feb; 44(1):7-12. PubMed ID: 10323090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
    Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
    Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of factor V Leiden with various clinical patterns of venous thromboembolism-the factor V Leiden paradox.
    Hirmerova J; Seidlerova J; Subrt I
    QJM; 2014 Sep; 107(9):715-20. PubMed ID: 24633260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A.
    Ordóñez AJ; Carreira JM; Alvarez CR; Rodríguez JM; Alvarez MV; Coto E
    Thromb Haemost; 2000 Feb; 83(2):352-4. PubMed ID: 10739402
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
    Yilmazer M; Kurtay G; Sonmezer M; Akar N
    Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.